TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
RXST

Rxsight Inc

Healthcare · Medical Devices

4.70$ +0.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement RXST
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
181.2% 88.4% 80.0% 56.5% 39.6% 29.3% 23.4%
-81.2% 11.6% 20.0% 43.5% 60.4% 70.7% 76.6%
1,319.5% 149.4% 108.4% 53.0% 32.6% 24.6% 28.7%
678.4% 103.4% 145.2% 119.7% 84.0% 72.5% 83.8%
1,974.6% 252.8% 253.6% 172.7% 116.6% 97.1% 112.4%
-2,055.8% -241.2% -233.6% -129.2% -56.2% -26.3% -35.8%
1.2% 3.5% 16.3% 10.1% 3.7% 0.0% 0.0%
5,633.4% 188.3% -215.5% -136.2% -54.5% -19.6% -28.9%
1.1% 0.4% 0.0% 0.0% 0.0% 0.0% 0.0%
5,632.3% 187.9% -215.5% -136.2% -54.6% -19.6% -29.0%
5,809.9% 219.1% -181.5% -117.9% -46.1% -17.0% -28.9%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?